{"id":15374,"date":"2021-12-03T10:23:10","date_gmt":"2021-12-03T09:23:10","guid":{"rendered":"http:\/\/miunidad.eu\/porib.com\/?p=15374"},"modified":"2022-03-21T10:25:19","modified_gmt":"2022-03-21T09:25:19","slug":"bastos-oreiro-m-de-las-heras-a-presa-m-casado-ma-pardo-c-martin-escudero-v-sureda-a-2","status":"publish","type":"post","link":"https:\/\/porib.com\/en\/bastos-oreiro-m-de-las-heras-a-presa-m-casado-ma-pardo-c-martin-escudero-v-sureda-a-2\/","title":{"rendered":"Bastos-Oreiro M, de las Heras A, Presa M, Casado MA, Pardo C, Mart\u00edn-Escudero V, Sureda A"},"content":{"rendered":"<div class=\"col80\">\n<p class=\"miniatura_foto\" style=\"text-align: justify;\"><strong><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-14157 alignleft\" src=\"https:\/\/porib.com\/wp-content\/uploads\/2021\/09\/ISPOR.jpg\" alt=\"\" width=\"120\" height=\"120\" \/><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong style=\"text-align: justify;\">Bastos-Oreiro M, de las Heras A, Presa M, Casado MA, Pardo C, Mart\u00edn-Escudero V, Sureda A <\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<\/div>\n<div class=\"col80\">\n<div class=\"col80p\">\n<h6><\/h6>\n<h6 style=\"text-align: justify;\">Axicabtagene ciloleucel and tisagenlecleucel for the treatment of relapsed\/refractory diffuse large B-cell lymphoma in Spain: a cost-effectiveness analysis<\/h6>\n<h6 style=\"text-align: justify;\"><strong>24th Annual European Congress International Society for Pharmacoeconomics &amp; Outcomes Research (ISPOR). Virtual. 30 nov-3 dic 2021<\/strong><\/h6>\n<p><a href=\"https:\/\/porib.com\/wp-content\/uploads\/2022\/03\/310.pdf\" target=\"_blank\" rel=\"noopener\">POSTER<\/a><\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Bastos-Oreiro M, de las Heras A, Presa M, Casado MA, Pardo C, Mart\u00edn-Escudero V, Sureda A &nbsp; &nbsp; Axicabtagene ciloleucel and tisagenlecleucel for the treatment of relapsed\/refractory diffuse large B-cell lymphoma in Spain: a cost-effectiveness analysis 24th Annual European Congress International Society for Pharmacoeconomics &amp; Outcomes Research (ISPOR). Virtual. 30 nov-3 dic 2021 POSTER<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"quote","meta":{"footnotes":""},"categories":[116,933,246],"tags":[],"class_list":["post-15374","post","type-post","status-publish","format-quote","hentry","category-ace-acu-tipo-de-proyecto","category-hematologia-oncohematologia","category-international-society-of-pharmacoeconomics-and-outcomes-research","post_format-post-format-quote"],"translation":{"provider":"WPGlobus","version":"2.10.3","language":"en","enabled_languages":["es","en"],"languages":{"es":{"title":true,"content":true,"excerpt":false},"en":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/15374"}],"collection":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/comments?post=15374"}],"version-history":[{"count":1,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/15374\/revisions"}],"predecessor-version":[{"id":15376,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/15374\/revisions\/15376"}],"wp:attachment":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/media?parent=15374"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/categories?post=15374"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/tags?post=15374"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}